Deutsche Telekom AG, together with its subsidiaries, provides integrated telecommunication services worldwide.
FAIL · Does not pass the screen
33.56 USD
At the last full screen 2026-08-20
Screened 2026-08-20 · the tape above runs as of 23:26 UTC · 4 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its distribution label.
Deutsche Telekom AG holds its Distribution at $33.56. The statistical read favours the buyers, held for 1 days.
As held on the ledger · 2026-08-20
Phase
Distribution · caution
Quantitative state
The statistical read favours the buyers, held for 1 days
Price at the screen
$33.56
Valuation
16.29 trailing · 10.53 forward price to earnings
Values screen
FAIL· score 70.0
Beta
0.32
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
91.51%
Below 33%
Interest-bearing debt is 91.5% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
4.88%
Below 33%
Cash held in interest-bearing accounts and securities is 4.9% of assets, under the one-third limit.
Pass
Receivables
0.00%
Below 49%
Money owed to the company is 0.0% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads AVOID: it trades at roughly a 33% discount to our $44.61 fair value, moderate competitive moat, 4.30% revenue growth.
Fair value range in USD, drawn from the 2026-08-20 screen. The gold marker is the market price at the same screen. A 32.9% margin of safety to the base estimate.
Third-party analyst targets: 3 covering, consensus Buy. The average target sits +25% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-08-20 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Global Telecom Giant Sinks Under Debt Burden
Imagine a titan of the telecommunications world, Deutsche Telekom AG, carrying a heavy load of debt that's weighing it down. The company operates across Germany, the United States, Europe, and offers a range of integrated telecommunication services, from fixed-network to more advanced solutions. With a forward P/E of 10.5x, it might seem like a steal, but appearances can be deceiving.
Why it stands out, or rather, why we're avoiding it, is due to its troubling debt ratio which has failed our ethical screen. Despite having a decent revenue growth of 4%, a profit margin of 7%, and a respectable ROE of 15%, the debt burden is a significant red flag. This is not a cyclical value trap; it's a case where the numbers on the surface don't tell the full story.
Risk sits heavily on this investment, primarily due to the debt ratio, which is a critical factor for us. Although three analysts have a consensus buy rating with a median target of $42, the ethical failing cannot be overlooked. The moat is only moderate, and with the ethical failings, we're steering clear. Analysis, not advice.
The risks · The things to watch: its business and earnings are exposed to Germany and to currency swings; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
DTEGY trades on OQX (the company is based in Germany). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-09-05Distribution$33.56+5.5%Entry 13
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 5.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 13%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (3 analysts) rates it none, with a mean price target of $42.
2026-08-06Distribution$31.82+5.3%Entry 12
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 5.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 13%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (3 analysts) rates it strong buy, with a mean price target of $41. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-05Distribution$30.21+0.0%Entry 11
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 13%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (3 analysts) rates it strong buy, with a mean price target of $41. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-04Distribution$30.21+0.0%Entry 10
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 13%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (3 analysts) rates it strong buy, with a mean price target of $41. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-03Distribution$30.21+0.0%Entry 9
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 13%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (3 analysts) rates it strong buy, with a mean price target of $41. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-02Distribution$30.21+0.0%Entry 8
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 13%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (3 analysts) rates it strong buy, with a mean price target of $41. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-01Distribution$30.21+0.0%Entry 7
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 13%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (3 analysts) rates it strong buy, with a mean price target of $41. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-31Distribution$30.21+0.0%Entry 6
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 13%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (3 analysts) rates it strong buy, with a mean price target of $41. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 13%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (3 analysts) rates it strong buy, with a mean price target of $41. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-26Markup$30.21-8.4%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 8.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 13%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (3 analysts) rates it strong buy, with a mean price target of $41.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.